Research Interest: Erythropoietin (EPO) is approved by FDA for administration to chronic renal disease patients and cancer patients to treat anemia, but my active area of research is to understand how EPO affects non-hematopoietic physiological response. My specific research interest is focussed on how EPO affects inflammation in the brain and periphery and regulates metabolic homeostasis
PTZ: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."